Evidence for involvement of th17 type responses in post kala azar dermal leishmaniasis (pkdl)

PLoS Neglected Tropical Diseases

Volumn 6, Issue 6, 2012, Pages

  Katara, Gajendra Kumar ^a   Ansari, Nasim Akhtar ^a   Singh, Avninder ^a   Ramesh, V ^b   Salotra, Poonam ^a  

^a SAFDARJUNG HOSPITAL CAMPUS   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CHEMOKINE RECEPTOR; CXCL2 CHEMOKINE; DEATH RECEPTOR 5; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MILTEFOSINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG; CYTOKINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POST KALA AZAR DERMAL LEISHMANIASIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKIN BIOPSY; SKIN LEISHMANIASIS; TH17 CELL; UPREGULATION; BIOSYNTHESIS; CHEMISTRY; IMMUNOLOGY; LEISHMANIA; LEISHMANIA DONOVANI; PATHOGENICITY; PLASMA; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MALE; MICROARRAY ANALYSIS; PLASMA; REAL-TIME POLYMERASE CHAIN REACTION; TH17 CELLS; YOUNG ADULT;

EID: 84863691178     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001703     Document Type: Article

References (55)

1. Herwaldt BL, (1999) Leishmaniasis. Lancet 354: 1191 1199.
2. Desjeux P, (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305 318.
3. Zijlstra EE, Musa AM, Khalil EAG, EI-Hassan IM, EI-Hassan AM, (2003) Post kala azar dermal leishmaniasis. Lancet Infect Dis 3: 87 98.
4. Singh R, Kumar D, Ramesh V, Negi NS, Singh S, et al. (2006) Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis. J Infect Dis 194: 302 306.
5. Sundar S, Kumar K, Chakravarty J, Agrawal S, Agrawal A, et al. (2006) Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine. Trans R Soc Trop Med Hyg 100: 698 700.
6. Saha S, Mondal S, Ravindran R, Bhowmick S, Modak D, et al. (2007) IL-10 and TGF-beta-mediated susceptibility in Kala-azar and Post-kala-azar dermal Leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J Immunol 179: 5592 5603.
7. Thakur CP, Kumar A, Mitra G, Thakur S, Sinha PK, et al. (2008) Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Indian J Med Res 128: 38 44.
8. Kumar D, Ramesh V, Verma S, Ramam M, Salotra P, (2009) Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine. Ann Trop Med Parasitol 103: 727 30.
9. Gasim S, Elhassan AM, Khalil EA, Ismail A, Kadaru AM, et al. (1998) High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin Exp Immunol 111: 64 69.
10. Ismail A, El Hassan AM, Kemp K, Gasim S, Kadaru AE, et al. (1999) Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile. J Pathol 189: 615 622.
11. Ansari NA, Ramesh V, Salotra P, (2006) Interferon (IFN)-gamma, tumor necrosis factor-alpha, interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis. J Infect Dis 194: 958 965.
12. Ansari NA, Katara GK, Ramesh V, Salotra P, (2008) Evidence for involvement of TNFR1 and TIMPs in pathogenesis of post-kala-azar dermal leishmaniasis. Clin Exp Immunol 154: 391 398.
13. Ganguly S, Mukhopadhyay D, Das NK, Chaduvala M, Sadhu S, et al. (2010) Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis. J Invest Dermatol 130: 1013 1022.
14. Katara GK, Ansari NA, Verma S, Ramesh V, Salotra P, (2011) Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients. PLoS Neg Trop Dis 5: e1171.
15. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203: 2271 2279.
16. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupé P, et al. (2008) A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 9: 650 657.
17. Crome SQ, Wang AY, Levings MK, (2010) Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 159: 109 119.
18. Pitta MG, Romano A, Cabantous S, Henri S, Hammad A, et al. (2009) IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest 119: 2379 2387.
19. Khader SA, Gopal R, (2010) IL-17 in protective immunity to intracellular pathogens. Virulence 1: 423 427.
20. Bacellar O, Faria D, Nascimento M, Cardoso TM, Gollob KJ, et al. (2009) Interleukin 17 production among patients with American cutaneous leishmaniasis. J Infect Dis 200: 75 78.
21. Verma S, Kumar R, Katara GK, Singh LC, Negi NS, et al. (2010) Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS One 5: e10107.
22. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, et al. (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126: 131 138.
23. Kostka SL, Dinges S, Griewank K, Iwakura Y, Udey MC, et al. (2009) IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J Immunol 182: 3039 3046.
24. Ivanov II, Zhou L, Littman DR, (2007) Transcriptional regulation of Th17 cell differentiation. Semin Immunol 19: 409 417.
25. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, et al. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 160: 3513 3521.
26. Miljkovic D, Trajkovic V, (2004) Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev 15: 21 32.
27. Brandonisio O, Panaro MA, Fumarola I, Sisto M, Leogrande D, et al. (2002) Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages. Clin Exp Med 2: 125 129.
28. Roychoudhury K, Dasgupta B, Sen P, Laskay T, Solbach W, et al. (2006) Evidence of direct interactions between the CC-chemokines CCL3, CCL4 and CCL5 and Leishmania promastigotes. Mol Biochem Parasitol 150: 374 377.
29. Grewal IS, Borrow P, Pamer EG, Oldstone MB, Flavell RA, (1997) The CD40-CD154 system in anti-infective host defense. Curr Opin Immunol 9: 491 497.
30. Heinzel FP, Rerko RM, Hujer AM, (1998) Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity. Cell Immunol 184: 129 142.
31. Mathur RK, Awasthi A, Wadhone P, Ramanamurthy B, Saha B, (2004) Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat Med 10: 540 544.
32. Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, et al. (1988) Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 54: 903 913.
33. Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, et al. (1997) Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6: 681 689.
34. Jayakumar A, Donovan MJ, Tripathi V, Ramalho-Ortigao M, McDowell MA, (2008) Leishmania major infection activates NF-kappaB and interferon regulatory factors 1 and 8 in human dendritic cells. Infect Immun 76: 2138 2148.
35. Kano A, Haruyama T, Akaike T, Watanabe Y, (1999) IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. Biochem Biophys Res Commun 257: 672 677.
36. Kolls JK, Linden A, (2004) Interleukin-17 family members and inflammation. Immunity 21: 467 476.
37. Solbach W, Laskay T, (2000) The host response to Leishmania infection. Adv Immunol 74: 275 317.
38. Boaventura VS, Santos CS, Cardoso CR, de Andrade J, Dos Santos WL, et al. (2010) Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines. Eur J Immunol 40: 2830 2836.
39. Lyakh L, Trinchieri G, Provezza L, Carra G, Gerosa F, (2008) Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol Rev 226: 112 131.
40. Ma X, Trinchieri G, (2001) Regulation of interleukin-12 production in antigen-presenting cells. Adv Immunol 79: 55 92.
41. Gerosa F, Baldani-Guerra B, Lyakh LA, Batoni G, Esin S, (2008) Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J Exp Med 205: 1447 1461.
42. Korn T, Bettelli E, Oukka M, (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27: 485 517.
43. Ansari NA, Kumar R, Gautam S, Nylén S, Singh OP, et al. (2011) IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J Immunol 186: 3977 3985.
44. Peruhype-Magalhaes V, Martins-Filho OA, Prata A, Silva Lde A, Rabello A, et al. (2006) Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection. Clin Exp Immunol 146: 124 132.
45. Gottlieb AB, Chamian F, Masud S, Cardinale I, Abello MV, et al. (2005) TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol 175: 2721 2729.
46. Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suárez-Fariñas M, et al. (2007) Amelioration of epidermal hyperplasia by TNF-α inhibition is associated with reduced Th17 responses. J Exp Med 204: 3183 3194.
47. Ansari NA, Sharma P, Salotra P, (2007) Circulating nitric oxide and C-reactive protein levels in Indian kala azar patients: correlation with clinical outcome. Clin Immunol 122: 343 348.
48. Cabrera M, Rodriguez O, Monsalve I, Tovar R, Hagel I, (2003) Variations in the serum levels of soluble CD23, nitric oxide and IgE across the spectrum of American cutaneous leishmaniasis. Acta Trop 88: 145 151.
49. Kumar R, Bumb RA, Salotra P, (2010) Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors. Immunology 130: 193 201.
50. Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, et al. (2009) T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31: 787 798.
51. Marin ND, Paris SC, Velez VM, Rojas CA, Rojas M, et al. (2010) Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis 90: 252 261.
52. Zhang L, Yang XQ, Cheng J, Hui RS, Gao TW, (2010) Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin Immunol 135: 108 117.
53. Wang Q, Zheng Y, Huang Z, Tian Y, Zhou J, et al. (2011) Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients. BMC Immunol 12: 25.
54. Crome SQ, Clive B, Wang AY, Kang CY, Chow V, et al. (2010) Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells. J Immunol 185: 3199 3208.
55. Awasthi A, Murugaiyan G, Kuchroo VK, (2008) Interplay between effector Th17 and regulatory T cells. J Clin Immunol 28: 660 670.